John Ellsworth, MD
Urology · St George, UTNPI 1083619043
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,510 of the $5,047 with a category attached, or 89.3%. Boston Scientific accounts for 80.5% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2023 at $1,861 and has fallen 81.7% since, to $341 in 2025.
Across 102 payments — averaging $49.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$4K
- AbbVie$331
- Procept Biorobotics Corporation$134
- Dendreon Pharmaceuticals LLC$120
- Sumitomo Pharma America, Inc.$113
- Axonics, Inc.$74
- plus $212 from 8 others
What the payments were for
- Travel & lodging$53811%
- Food & beverage$4,51089%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 62 | $4,064 |
| AbbVie(2 entities) | 17 | $331 |
| Procept Biorobotics Corporation | 1 | $134 |
| Dendreon Pharmaceuticals LLC | 1 | $120 |
| Sumitomo Pharma America, Inc. | 6 | $113 |
| Axonics, Inc. | 2 | $74 |
| Myriad Genetic Laboratories, Inc. | 4 | $55 |
| Urovant Sciences Inc | 2 | $36 |
| Johnson & Johnson | 2 | $36 |
| 180 Medical, Inc. | 1 | $23 |
| Endo Pharmaceuticals Inc. | 1 | $18 |
| Halozyme Inc | 1 | $17 |
| Antares Pharma, Inc. | 1 | $13 |
| Astellas Pharma US Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Moses 550 D\F\L$908
- LithoVue$649
- TRIA$226
- AquaBeam Robotic System$134
- PROVENGE$120
How this compares
$5,047 in reported general payments places this provider in the 55th percentile of 96 urology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 66 | $73,838 |
| Tamsulosin Hcl | 1,001 | $28,316 |
| GemtesaVibegron | 31 | $25,154 |
| Finasteride | 472 | $7,314 |
| Solifenacin Succinate | 221 | $6,902 |
| Silodosin | 72 | $5,498 |
| Estradiol | 72 | $4,228 |
| Tadalafil | 36 | $3,443 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 91 | $3,009 |
| Ciprofloxacin Hcl | 328 | $2,409 |
| Testosterone Cypionate | 51 | $2,313 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 94 | $2,264 |
| Testosterone | 12 | $2,208 |
| Dutasteride | 43 | $2,042 |
| NitrofurantoinNitrofurantoin Macrocrystal | 35 | $1,659 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $13 | $73,83866 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $113 | $25,15431 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 96 urology providers in Utah.
Other urology in St George
- Bryant WhitingSt George$12K
- Thomas BrintonSt George$8K
- Robert CopeSt George$3K
- Scott SalmonSt George$3K
- Steven GangeSlc$1.5M
- William BrantSalt Lake City$290K
- Roscoe NelsonAmerican Fork$152K
- Nathan PursifullAmerican Fork$86K
- Benjamin McCormickSalt Lake City$67K
- Richard MaternSalt Lake City$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.